Biosimilars Market: How Is the Developing World Biosimilar Market Growing?
Emerging market biosimilars — non-originator biologics (NOBs) and regulatory-pathway biosimilars providing biologic treatment access to patients in India, China, Brazil, and other developing countries at prices accessible within local healthcare budgets — represent the largest unmet biologic access opportunity globally, with the Biosimilars Market reflecting developing world...
0 Kommentare 0 Anteile 201 Ansichten 0 Vorschau